'Holy Grail' discovery could mean 'nobody needs to worry about their MS getting worse' – study

The paper, published in Acta Neuropathologica on Wednesday, also said that a common diabetes drug prevent disability progression in the neurological condition.

A “Holy Grail” molecular target has been discovered to protect nerves from damage in multiple sclerosis (MS), a study has said.

The paper, published in Acta Neuropathologica on Wednesday, also said that a common diabetes drug could help enhance this new-found natural mechanism and prevent disability progression in the neurological condition.